Ritonavir
| 證據等級: L5 | 預測適應症: 3 個 |
目錄
Ritonavir: Evaluation Report — Insufficient TxGNN Prediction Data
One-Sentence Summary
Ritonavir is an HIV protease inhibitor widely used as a pharmacokinetic booster in combination antiviral regimens (e.g., Paxlovid, lopinavir/ritonavir). The current Evidence Pack contains no TxGNN-predicted new indications, and the drug is not registered in Taiwan. Due to critical data gaps across prediction, regulatory, mechanism, and safety dimensions, a full repurposing evaluation cannot be completed at this stage.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | HIV infection (general pharmaceutical knowledge; absent from regulatory data) |
| Predicted New Indication | Not available |
| TxGNN Prediction Score | Not available |
| Evidence Level | Undetermined — no prediction data present |
| Taiwan Market Status | ✗ Not marketed |
| Number of Authorizations | 0 |
| Recommended Decision | Hold |
Safety Considerations
No safety data is available for this Evidence Pack. All warning, contraindication, and drug interaction fields returned as empty or missing.
Please refer to the package insert for safety information.
Conclusion and Next Steps
Decision: Hold
Rationale: The Evidence Pack for Ritonavir is critically incomplete across all four evaluation dimensions — TxGNN prediction, regulatory status, mechanism of action, and safety profile. Without a predicted indication to evaluate, no repurposing case can be constructed or assessed.
To proceed, the following is needed:
- TxGNN prediction results —
predicted_indicationsmust be populated with at least one candidate indication and associated evidence (clinical trials, literature) - Mechanism of action (MOA) — retrieve from DrugBank API (DG002: High severity gap)
- Package insert safety data — key warnings, contraindications, and drug interactions from TFDA or equivalent source (DG001: Blocking severity gap)
- Original indication confirmation — verify approved indications from Taiwan TFDA or international regulatory sources (EMA/FDA)
- Drug interaction profile — DDI query returned
not_found; re-query with alternate sources (e.g., DrugBank DDI, clinical pharmacology databases)Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.